Sanifit Therapeutics (private company)

See something wrong or missing? Let us know
Offices:Palma de Mallorca
Business model:B2B

Sanifit is a clinical-stage biopharmaceutical company focused on treatments for progressive vascular calcification disorders. The company started activities in 2007 as a spin-off from the University of the Balearic Islands, and has offices in Spain and the USA.

Investors: we tracked 9 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 80.9M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Sanifit Therapeutics

Name Criteria
Denmark NMD Pharma
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark Cytoki Pharma
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Causaly
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom ReViral
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Denmark STipe Therapeutics
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark AFYX Therapeutics
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Netherlands Citryll
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Exiscientia
63%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Denmark Synklino
62%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Top